Abstract
Objective:
To evaluate the prognostic value of Piezo1 expression in the distal anastomosed ureter for predicting pyeloplasty outcomes.
Methods:
Distal anastomosed ureter specimens from 28 patients diagnosed with primary ureteropelvic junction obstruction (UPJO) undergoing laparoscopic pyeloplasty were analyzed. Immunohistochemistry assessed Piezo1 expression, and Masson's trichrome staining determined the collagen-to-muscle ratio (CM ratio). Postoperative outcomes at 12 months were categorized as excellent improvement, good improvement, mild improvement, no improvement, or deterioration based on hydronephrosis severity scores (HSS). Associations between pathological markers (Piezo1 and CM ratio) and surgical outcomes were examined.
Results:
The cohort included 28 patients (22 male, 6 female), with a median age of 64.3 months (IQR: 15.4–102.6). Compared to the unsatisfactory outcome group (no improvement/deterioration), the satisfactory group (excellent/good/mild improvement) exhibited significantly lower Piezo1 expression and CM ratio in the distal anastomosed ureter. Piezo1 expression strongly correlated with CM ratio (r = 0.687, p < 0.0001). Piezo1 expression level threshold of <2.765% predicted satisfactory outcomes.
Conclusion:
Distal anastomosed ureter Piezo1 expression is a promising prognostic biomarker for pyeloplasty outcomes.
Introduction
Ureteropelvic junction obstruction (UPJO) is the most common etiology of hydronephrosis in pediatric populations, with an estimated global incidence of 1:1500 (–). Since its initial introduction in 1949, the Anderson-Hynes dismembered pyeloplasty has remained the gold-standard reconstructive procedure for pediatric UPJO (). Although the surgery demonstrates high success rates, with reported failure rates of approximately 5% (–), the precise pathogenesis of UPJO remains unclear. In clinical practice, surgeons routinely submit resected stenotic segments for histopathological evaluation; however, findings are typical fibrosis and inflammatory cell infiltration with limited prognostic value ().
Previous studies have demonstrated that interstitial cells of Cajal (ICC) play a crucial role in modulating ureteral peristalsis, with reduced ICC density at the UPJ being implicated in the pathogenesis of hydronephrosis (–). Additionally, characteristic histopathological features of UPJO include smooth muscle hypertrophy, excessive collagen deposition, and neuron deficiency (–). While existing research has primarily focused on UPJ specimens to elucidate UPJO etiology, the prognostic significance of pathological markers in the resected distal ureter remains poorly understood.
The Piezo-type mechanosensitive ion channel component 1 (Piezo1) is a mechanotransduction protein that gates in response to mechanical stimuli, transducing physical forces into electrochemical signals to modulate diverse physiological processes including vascular tone regulation, cellular differentiation, and urinary tract dynamics (, ). Immunohistochemical studies have identified Piezo1 localization in urothelial cells, ureteral smooth muscle, and renal pelvis, where it contributes to ureteral peristalsis modulation (). However, the expression profile of Piezo1 in human ureter remains elusive, and its potential association with pyeloplasty outcomes has not been investigated.
This study aimed to characterize Piezo1 expression patterns in distal ureteral tissues and evaluate its potential as a predictive biomarker for pyeloplasty outcomes.
Materials and methods
Study design
This retrospective study was conducted at the Children's Hospital of Nanjing Medical University from September 2022 to November 2023, with approval from the Institutional Review Board (Approval number: 202503017-1). All procedures complied with the Declaration of Helsinki principles, and written informed consent was obtained from all participants' legal guardians. The study included pediatric patients who underwent laparoscopic pyeloplasty for primary UPJO. Exclusion criteria included: (1) concurrent renal malformation (duplex kidney, solitary kidney, horseshoe kidney, or ectopic kidney); (2) bilateral UPJO; (3) vesicoureteral reflux; (4) secondary procedures or crossing vessel for UPJO; and (5) incomplete clinical data or lost in follow-up. The schedule for routine follow-up was at 3, 6, 12, 18 and 24 months after surgery under outpatient or with telephone interview.
Treatment
All patients underwent standardized assessment including renal ultrasonography for measurement of anteroposterior diameter (APD) and cortical thickness evaluation. Diuretic renography was performed to assess differential renal function (DRF) and urinary drainage patterns. Surgical indications included: (1) progressive hydronephrosis (Society for Fetal Urology grade III-IV) on ultrasonography; (2) presence of clinical symptoms (renal colic, urinary tract infections, hematuria, or nephrolithiasis); and (3) impaired renal function (DRF <40%) or obstructive drainage pattern (T1/2 >20 min post-furosemide administration). All surgical procedures were performed by three experienced surgeons with the same qualifications in laparoscopic surgery. Baseline characteristics including patient's age, gender, side, weight, diagnosis, APD and differential renal function (DRF) were recorded preoperatively.
Pathological analysis
The collected distal anastomosed ureter samples were fixed with 10% buffered formalin and embedded by paraffin. Then, paraffin-embedded samples were sectioned into 4-μm thickness for H&E staining. For Masson's trichrome staining, sections were stained following conventional Masson's trichrome, which indicates the collagen as blue and smooth muscle as red. The collagen to muscle ratio (CM ratio) was analyzed according to Kim et al (). Immunohistochemical for evaluation the expression of Piezo1 were conducted by incubating with H2O2 before treatment with anti-Piezo1 antibody (1:100, proteintech, China). The positive areas of piezo1 were measured under a light microscope. All histopathological assessments were conducted in a blinded manner.
Definition and outcomes
In present study, pyeloplasty outcomes after surgery were defined based on hydronephrosis severity score (HSS), which was proposed by Babu et al (). Generally, HSS was calculated by three parameters including DRF, drainage curve pattern, and US grade. Each item was scored from 0 to 4 points. Thus, the total HSS ranged from 0 to 12 points (Table 1). Finally, pyeloplasty outcomes were defined as excellent improvement, good improvement, mild improvement, no improvement and deterioration at 12 months after surgery based on the difference between preoperative and postoperative HSS values. Patients presented with excellent improvement, good improvement, mild improvement were classified as satisfactory group; while patients presented with no improvement and deterioration were defined as unsatisfactory group.
Table 1
| Hydronephrosis severity score = A + B + C | |||
|---|---|---|---|
| Score | A. DRF | B. Drainage pattern | C. APD |
| 0 | ≥45% | Good drainage starts even before frusemide | ≤5 mm |
| 1 | 40–44% | Good drainage starts only after frusemide | 6–9 mm |
| 2 | 35–39% | Delayed drainage after frusemide (equivocal) | 10–19 mm |
| 3 | 30–34% | Poor response to frusemide (plateau) + partial clearance in 2-h | 20–29 mm |
| 4 | <30% | No response to frusemide (up-raising curve) + stasis in 2-h | ≥30 mm |
Hydronephrosis severity score is determined by three parameters: differential renal function (DRF), drainage pattern and ultrasound grade/anteroposterior diameter (APD).
Statistical analysis
Numerical variables were presented as mean ± standard deviation (SD) or median with interquartile range (IQR), depending on their normality distribution. Accordingly, the t-test or Mann–Whitney U-test was conducted as appropriate. Categorical variables were expressed as frequencies with percentages and were compared using the chi-square test or Fisher's exact test. The positive areas of Piezo1 in distal ureter were measured under a light microscope and calculated by ImageJ software (version 1.51, USA). The prognostic potential of Piezo1 was determined using receiver operating characteristic (ROC) curve analysis, with results expressed as the area under the curve (AUC). The optimal cutoff value was identified based on the combined consideration of sensitivity and specificity. The ROC curves were constructed using MedCalc software (version 20.015). All statistical analyses in this study were performed using Stata (version 15.1), with a p-value <0.05 considered statistically significant.
Results
Baseline characteristic
Overall, 28 patients were included in present study. The median age of the entire population at surgery was 64.3 (IQR: 15.4–102.6) months with 22 (78.6%) male patients and 6 (21.4%) female patients. The median weight was 19.5 (IQR: 10.0–32.8) kg, and 22 patients (78.6%) was confirmed in left side. The median pre-APD and DRF were 32.5 (IQR: 23.5–45.5) mm and 43.6 (IQR: 32.1–46.7), respectively. Most patients (82.1%) were prenatally diagnosed with hydronephrosis. The median follow-up duration was 16 (IQR: 12–18) months. Detailed patients' characteristics were shown in Table 2.
Table 2
| Variable | Overall (n = 28) |
|---|---|
| Gender | |
| Male | 22 (78.6%) |
| Female | 6 (21.4%) |
| Side | |
| Left | 22 (78.6%) |
| Right | 6 (21.4%) |
| Age, months | 64.3 [15.4–102.6] |
| Weight, kg | 19.5 [10.0–32.8] |
| Diagnosis | |
| Prenatally | 23 (82.1%) |
| Postnatally | 5 (17.9%) |
| Pre-APD, mm | 32.5 [23.5–45.5] |
| DRF, % | 43.6 [32.1–46.7] |
Baseline characteristics of included patients.
Clinical outcomes
Table 3 represented the clinical outcomes. The results showed that 8 patients were excellent improvement, 11 patients were good improvement, and 4 patients were mild improvement. However, two patients presented with no improvement and they were still under follow-up. There were 3 patients presented with deterioration and all received a repeated pyeloplasty.
Table 3
| Clinical outcome | Pre HSS-Post HSS | N = 28 | Piezo 1 area (%) | CM ratio |
|---|---|---|---|---|
| Excellent improvement | 5–6 | 8 | 1.768 | 0.772 |
| Good improvement | 3–4 | 11 | 1.602 | 0.786 |
| Mild improvement | 1–2 | 4 | 1.834 | 0.714 |
| No improvement | 0 | 2 | 3.158 | 1.900 |
| Deterioration | −1 or less | 3 | 3.525 | 1.871 |
Clinical outcomes and quantitative analysis of pathological markers of included patients.
Pathological outcomes
The representative images were shown in Figure 1. The median positive area of piezo1 at distal ureter was significantly lower in excellent improvement (p = 0.004), good improvement (p < 0.001) and mild improvement (p = 0.021) compared to deterioration group. While no significant difference was found between no improvement and deterioration group (3.525 vs. 3.158; p = 0.455). Additionally, the CM ratio was significantly lower in excellent improvement (p < 0.001), good improvement (p = 0.010) and mild improvement (p = 0.003) compared to deterioration group at distal ureter. And there was no significance difference between no improvement and deterioration group (1.871 vs. 1.900; p = 0.927) (Figure 2).
Figure 1
Figure 2
Prognostic potential of Piezo1
To explore the clinical implications of Piezo1, the correlation analysis between Piezo1 and CM ratio in distal ureter was conducted. The results indicated that piezo1 expression had a good correlation with CM ratio (r = 0.687; p < 0.0001) (Figure 3).
Figure 3
To further elucidate the prognostic value of Piezo1 in pyeloplasty outcomes, the ROC curve was constructed. Correspondingly, the pyeloplasty outcomes were classified as satisfactory group (excellent improvement, good improvement, and mild improvement) and unsatisfactory group (no improvement and deterioration) according to HSS. The ROC curve was shown in Figure 4. The results suggested that Piezo1 had a high predictive value for pyeloplasty outcomes, with an area under the curve (AUC) of 0.991. The best cutoff value of Piezo1 was 2.765%, with the sensitivity of 100.00% and the specificity of 95.65%.
Figure 4
Discussion
While pyeloplasty is generally successful in treating UPJO, researchers have sought to identify histological markers in predicting surgical outcomes. Previous studies have demonstrated the prognostic significance of ICC, neuron density, and CM ratio at the UPJ (, , ). In this study, we investigated Piezo1 expression in the distal ureter and demonstrated its potential as a predictive biomarker for pyeloplasty outcomes.
Yang et al. () reported a significant reduction in ICC density within UPJ samples compared to controls, suggesting a potential role for ICC in UPJO pathogenesis. Additionally, Senol et al. () pointed that the number of ICC was decreased in most UPJO cases, which was similar to the study reported by Inugala et al. () in which 52% of UPJO patients were defined as negative of ICC. While the direct evidence between ICC and ureteral motility is insufficient, previous studies have demonstrated that a wide range of ion channels and receptors were expressed on ICC, which were involved in modulating smooth muscle cells contraction ().
The relationship between histopathological features and pyeloplasty outcomes remains controversial. Issi et al. () conducted a retrospective study including 52 patients and reported that there were not any significant differences in collagen type 3, elastin, fibrosis, or ICC between successful and unsuccessful surgery group. While some authors failed to demonstrate the association between pathological markers and outcomes and they claimed that surgical techniques were more important, we believe that they missed the association because they only focused on the UPJ segment itself. It is essential to comprehensively analyze the resected distal ureter as it was used for anastomosis and determines the long-term outcomes.
Babu et al. () demonstrated that pathological parameters at the anastomotic ureteral end correlate more strongly with clinical outcomes than those at the UPJ. Their findings indicated that, compared to ICC and neurons, the CM ratio at the anastomotic site serves as a superior predictor of pyeloplasty success. This was further supported by Kim et al. (), who confirmed the prognostic value of CM ratio in assessing post-pyeloplasty recovery. Additionally, Ulusoy et al. (). Indicated that renal pelvis collagen ratio was significantly increased in patients with severe renal function loss and stated that analysis of renal pelvis collagen ratio would help to evaluate renal function in advance in congenital hydronephrosis. Our study revealed that Piezo1 is predominantly expressed in the distal ureter and shows significant positive correlation with the CM ratio (r = 0.687, p < 0.0001). Importantly, Piezo1 expression levels at the anastomotic site effectively predicted surgical outcomes. This finding aligns with established literature documenting Piezo1's involvement in fibrotic processes in liver and kidney tissues (, ). Through receiver operating characteristic (ROC) analysis, we identified ≤2.765% Piezo1-positive area as a predictive threshold for successful pyeloplasty outcomes. While routine histological examination of UPJ specimens typically reveals only typical fibrosis and inflammatory cells, quantitative assessment of Piezo1 expression in the anastomotic ureteral segment may provide clinically meaningful prognostic information.
While immunohistochemistry for Piezo1 may not be widely available or affordable, we recommend routine Masson's trichrome staining with quantitative CM ratio analysis as a practical alternative. Our findings strongly support the prognostic value of distal anastomosed ureteral Piezo1 expression assessment in predicting pyeloplasty outcomes. The results in present study have important clinical implications as patients demonstrating unfavorable histopathological characteristics in the distal ureter may benefit from more intensive postoperative surveillance, and prolonged DJ stent retention could be considered in such cases to potentially reduce recurrence risk. This stratified approach based on histopathological risk assessment may optimize postoperative management while maintaining cost-effectiveness.
It has several limitations that should be acknowledged. First, the study is limited by its retrospective nature and relative small numbers. Second, the exclusion of patients with crossing vessels introduces potential selection bias, warranting specific investigation of this subgroup in future studies. Third, while we identified Piezo1 expression as a predictive biomarker for pyeloplasty outcomes, the precise molecular mechanism remains unclear. Additional cellular and animal studies are needed to elucidate the underlying molecular pathways involving Piezo1 in ureteral function and repair. Further research should pay more attention to developing intraoperative markers to help identify normal ureters by frozen sections or special staining during pyeloplasty.
Conclusion
Distal anastomosed ureter Piezo1 expression is a promising prognostic biomarker for pyeloplasty outcomes.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by Research Ethics Board of Children's Hospital of Nanjing Medical University (202503017-1). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants' legal guardians/next of kin.
Author contributions
ZJ: Writing – review & editing, Conceptualization, Methodology, Writing – original draft, Formal analysis, Investigation. LX: Data curation, Methodology, Conceptualization, Software, Writing – review & editing, Project administration, Writing – original draft. HL: Writing – review & editing, Data curation, Validation, Writing – original draft. GY: Investigation, Validation, Writing – review & editing, Writing – original draft.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Acknowledgments
We sincerely thank the children and their guardians who agreed to participate in this study.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
LiuXHuangCGuoYYueYHongJ. Comparison of DJ stented, external stented and stent-less procedures for pediatric pyeloplasty: a network meta-analysis. Int J Surg. (2019) 68:126–33. 10.1016/j.ijsu.2019.07.001
2.
KoffSA. Requirements for accurately diagnosing chronic partial upper urinary tract obstruction in children with hydronephrosis. Pediatr Radiol. (2008) 38 Suppl 1:S41–8. 10.1007/s00247-007-0590-2
3.
VemulakondaVM. Ureteropelvic junction obstruction: diagnosis and management. Curr Opin Pediatr. (2021) 33:227–34. 10.1097/MOP.0000000000000994
4.
O'ReillyPHBroomanPJMakSJonesMPickupCAtkinsonCet alThe long-term results of Anderson-Hynes pyeloplasty. BJU Int. (2001) 87:287–9. 10.1046/j.1464-410x.2001.00108.x
5.
LiJLiZHeYFanSLiuPYangZet alDevelopment of the prediction model for negative outcomes after primary laparoscopic pyeloplasty in children: a retrospective study of 535 patients. Transl Androl Urol. (2022) 11:1680–90. 10.21037/tau-22-327
6.
RomaoRLKoyleMAPippiSJAlotayAFigueroaVHLorenzoAJet alFailed pyeloplasty in children: revisiting the unknown. Urology. (2013) 82:1145–7. 10.1016/j.urology.2013.06.049
7.
ThomasJCDeMarcoRTDonohoeJMAdamsMCPopeJTBrockJR. Management of the failed pyeloplasty: a contemporary review. J Urology. (2005) 174:2363–6. 10.1097/01.ju.0000180420.11915.31
8.
MutTAcarÖOktarTKılıçaslanIEsenTAnderHet alIntraoperative inspection of the ureteropelvic junction during pyeloplasty is not sufficient to distinguish between extrinsic and intrinsic causes of obstruction: correlation with histological analysis. J Pediatr Urol. (2016) 12:221–3. 10.1016/j.jpurol.2016.02.016
9.
SolariVPiotrowskaAPPuriP. Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction. J Urology. (2003) 170:2420–2. 10.1097/01.ju.0000097401.03293.f0
10.
YangXZhangYHuJ. The expression of Cajal cells at the obstruction site of congenital pelviureteric junction obstruction and quantitative image analysis. J Pediatr Surg. (2009) 44:2339–42. 10.1016/j.jpedsurg.2009.07.061
11.
SenolCOnaranMGurocakSGonulIITanMO. Changes in Cajal cell density in ureteropelvic junction obstruction in children. J Pediatr Urol. (2016) 12:81–9. 10.1016/j.jpurol.2015.08.010
12.
KayaCBogaertGde RidderDSchwentnerCFritschHOswaldJet alExtracellular matrix degradation and reduced neural density in children with intrinsic ureteropelvic junction obstruction. Urology. (2010) 76:185–9. 10.1016/j.urology.2009.09.097
13.
HosgorMKaracaIUlukusCOzerEOzkaraESamBet alStructural changes of smooth muscle in congenital ureteropelvic junction obstruction. J Pediatr Surg. (2005) 40:1632–6. 10.1016/j.jpedsurg.2005.06.025
14.
KajbafzadehAMPayabvashSSalmasiAHMonajemzadehMTavangarSM. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction. J Urology. (2006) 176:718–23, 723. 10.1016/j.juro.2006.03.041
15.
TangHZengRHeEZhangIDingCZhangA. Piezo-type mechanosensitive Ion channel component 1 (Piezo1): a promising therapeutic target and its modulators. J Med Chem. (2022) 65:6441–53. 10.1021/acs.jmedchem.2c00085
16.
GudipatySALindblomJLoftusPDReddMJEdesKDaveyCFet alMechanical stretch triggers rapid epithelial cell division through Piezo1. Nature. (2017) 543:118–21. 10.1038/nature21407
17.
LiuHHuJZhengQFengXZhanFWangXet alPiezo1 channels as force sensors in mechanical force-related chronic inflammation. Front Immunol. (2022) 13:816149. 10.3389/fimmu.2022.816149
18.
KimWJYunSJLeeTSKimCWLeeHMChoiH. Collagen-to-smooth muscle ratio helps prediction of prognosis after pyeloplasty. J Urology. (2000) 163:1271–5. 10.1016/S0022-5347(05)67759-2
19.
BabuRVenkatachalapathyESaiV. Hydronephrosis severity score: an objective assessment of hydronephrosis severity in children-a preliminary report. J Pediatr Urol. (2019) 15:61–8. 10.1016/j.jpurol.2018.09.020
20.
InugalaAReddyRKRaoBNReddySPOthuluruRKanniyanLet alImmunohistochemistry in ureteropelvic junction obstruction and its correlation to postoperative outcome. J Indian Assoc Pediatr Surg. (2017) 22:129–33. 10.4103/jiaps.JIAPS_254_16
21.
WangTFuMYanXSongHZhangW. Expression and clinical implications of PARs in the stenotic tissue of ureteropelvic junction obstruction. Front Pediatr. (2023) 11:1286786. 10.3389/fped.2023.1286786
22.
IssiODeliktasHGedikAOzekinciSBircanMKSahinH. Does the histopathologic pattern of the ureteropelvic junction affect the outcome of pyeloplasty. Urol J. (2015) 12:2028–31.
23.
BabuRVittalrajPSundaramSManjushaMPRamananVSaiV. Comparison of different pathological markers in predicting pyeloplasty outcomes in children. J Pediatr Surg. (2020) 55:1616–20. 10.1016/j.jpedsurg.2019.08.015
24.
UlusoyOAydınEAteşOHakgüderGÖzerEOlgunerMet alClues for the early loss of renal function in congenital hydronephrosis: analysis of renal pelvis collagen ratio, diuresis renography and upper urinary tract morphology. J Pediatr Urol. (2023) 19(2):191–7. 10.1016/j.jpurol.2023.03.018
25.
WangYWangJZhangJWangYWangYKangHet alStiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis. Sci Adv. (2024) 10:eadj3289. 10.1126/sciadv.adj3289
26.
ZhaoXKongYLiangBXuJLinYZhouNet alMechanosensitive Piezo1 channels mediate renal fibrosis. Jci Insight. (2022) 7(7):e152330. 10.1172/jci.insight.152330
Summary
Keywords
Piezo1, pathological markers, distal ureter, predictive value, pyeloplasty outcomes
Citation
Zhou J, Lu X, Huang L and Guo Y (2025) Pathological markers of Piezo1 at distal anastomosed ureter in predicting pyeloplasty outcomes in children. Front. Pediatr. 13:1612706. doi: 10.3389/fped.2025.1612706
Received
16 April 2025
Accepted
14 October 2025
Published
28 October 2025
Volume
13 - 2025
Edited by
Miguel Alfedo Castellan, University of Miami, United States
Reviewed by
Derya Yayla, Izmir City Hospital, Türkiye
Gulce Hakguder, Dokuz Eylül Üniversitesi Tıp Fakültesi Cocuk Cerrahisi Anabilim Dalı, Türkiye
Updates
Copyright
© 2025 Zhou, Lu, Huang and Guo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yunfei Guo guozhaooso@163.com
† These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.